Rating Change
HC Wainwright & Co. reiterated its Buy rating on PDS Biotechnology Corporation (NASDAQ:PDSB) on August 13, 2026.
reiterateNASDAQ:PDSB
HC Wainwright & Co. Reiterates Buy Rating on PDS Biotechnology Corporation (PDSB)
HC Wainwright & Co. reiterated its Buy rating on PDS Biotechnology Corporation (NASDAQ:PDSB) on August 13, 2026.
At publication ·
What changed
PDS Biotechnology Corporation (NASDAQ:PDSB) · reiterate
- Firm
- HC Wainwright & Co.
- Rating
- Buy to Buy
- Price at event
- $0.23
- Market capitalization
- $49.9M
At a glance
Key takeaways
- HC Wainwright & Co. reiterated a Buy rating on PDS Biotechnology Corporation (PDSB) on August 13, 2026, with the stock trading at $0.23 and a market capitalization of $49.9 million.
Market Context
PDS Biotechnology Corporation operates in the Healthcare sector. The stock currently trades at $0.23 with a market capitalization of $49.9M. The stock has declined 77.6% over the past 52 weeks.
Analyst coverage from HC Wainwright & Co. provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for PDS Biotechnology Corporation.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for PDS Biotechnology Corporation
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Aug 13, 2026 | HC Wainwright & Co. | Buy | N/A |
| Apr 15, 2026 | HC Wainwright & Co. | Buy | N/A |
| Nov 25, 2025 | B. Riley Securities | Buy | N/A |
| Nov 13, 2025 | HC Wainwright & Co. | Buy | N/A |
| Jul 01, 2025 | HC Wainwright & Co. | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View PDSB Stock Page
Frequently Asked Questions
What does the Buy rating mean for PDSB?
A rating of Buy from HC Wainwright & Co. reflects the analyst's outlook on PDS Biotechnology Corporation (NASDAQ:PDSB). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PDSB forecast page.